Volatile inhalant intoxication

Volatile inhalant intoxication is a clinically significant transient condition that develops during or shortly after the consumption of a volatile inhalant that is characterized by disturbances in consciousness, cognition, perception, affect, behavior, or coordination. These disturbances are caused by the known pharmacological effects of volatile inhalants and their intensity is closely related to the amount of volatile inhalant consumed. They are time-limited and abate as the volatile inhalant is cleared from the body. Presenting features may include euphoria, impaired judgment, aggression, somnolence, stupor or coma, dizziness, tremor, lack of coordination, slurred speech, unsteady gait, lethargy and apathy, psychomotor retardation, and visual disturbances. Muscle weakness and diplopia may occur. Use of volatile inhalants may cause cardiac arrhythmia, cardiac arrest, and death. Inhalants containing lead (e.g. some forms of petrol/gasoline) may cause confusion, irritability, coma and seizures.

How to recognise

In the ICD-11 framework, the core symptoms taken into account when recognising Volatile inhalant intoxication are:

• brak koordynacji
• niewyraźna mowa

Differential diagnosis

When diagnosing Volatile inhalant intoxication, the following ICD-11 disorders should be considered in the differential diagnosis:

• Zaburzenia transowo-opętaniowe (6B63)

Frequently asked questions

What disorders are in the differential diagnosis of Volatile inhalant intoxication?

The differential diagnosis of Volatile inhalant intoxication (6C4B.3) includes: Zaburzenia transowo-opętaniowe (6B63).

WHO ICD-11 source

View this entry in the official WHO ICD-11 browser: 6C4B.3 – WHO ICD-11

Notes

Proszę zakodować również jednostkę chorobową (schorzenie) będące przyczyną